BCOP Board Certified Oncology Pharmacist Practice Test

Candidates must hold a current, active pharmacist license in the U.S. or another jurisdiction. Additionally, they must complete one of two pathways: 1) Four years of practice experience with at least 50% of time spent in oncology pharmacy activities (post-licensure), OR 2) Completion of a PGY2 residency in oncology pharmacy. Practice experience must be within the seven years prior to the application date.

The BCOP exam is a computer-based test consisting of 175 multiple-choice questions, of which 150 are scored. Candidates are given 4 hours to complete the exam. Questions are application-based and scenario-driven, designed to assess the candidate's ability to analyze information, make clinical judgments, and solve problems across the domains outlined in the official exam content blueprint.

BCOP certification is valid for seven years. Recertification can be achieved through either passing the recertification examination or completing a minimum of 100 hours of continuing education (CE) in oncology-specific content, along with maintaining an active pharmacist license. The CE pathway requires that a portion of the hours are practice-based activities, ensuring ongoing engagement in the specialty.

A PGY2 oncology residency provides structured, post-graduate training and experience, which is one pathway to meet the eligibility requirements for the BCOP exam. The BCOP certification itself is an independent assessment and validation of the knowledge and skills acquired through that training and/or subsequent experience. It is a standardized, external credential that demonstrates competency to employers and the public, whereas residency completion signifies the fulfillment of a specific training program.

Institutions benefit from employing BCOP-certified pharmacists through enhanced quality and safety of oncology medication use, reduced medication errors, and improved patient outcomes. The credential supports compliance with standards from accrediting bodies like ASCO's Quality Oncology Practice Initiative (QOPI) and The Joint Commission. It also elevates the institution's reputation, aids in recruiting top talent, and provides a benchmark for clinical ladder advancement and specialized service development.